"MBX is entering 2025 with strong momentum following significant and transformational progress in 2024,” said Kent Hawryluk, President and Chief Executive Officer of MBX Biosciences. "We are poised to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback